CLINICAL_TRIALS
trial_result
· 2018-12-17
Clinical Trial Update: Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) [Phase 2, Phase 3]
Summary
Phase 2/3 trial updating on prevention of delayed graft function with eculizumab therapy; study completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Delayed Graft Function | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-12-17